Zivo Bioscience (ZIVO) Gets a Buy From Maxim Group
TipRanksApr 12 07:36 ET
Zivo Bioscience Inc Faces Nasdaq Delisting and Shifts to OTC Markets
TipRanksFeb 15 17:07 ET
ZIVO Bioscience Reports Additional Findings From Positive 42-Day Coccidiosis Challenge Study
Reduction in intestinal damage enables poultry farms to optimize feed utilizationBLOOMFIELD HILLS, Mich.--(BUSINESS WIRE)--Zivo Bioscience, Inc. (OTCQB: ZIVO) (the "Company"), a biotech/agtech R&D com
BusinesswireFeb 7 16:54 ET
ZIVO Bioscience Announces Uplisting to OTCQB Market
Zivo Bioscience, Inc. (OTCQB: ZIVO) (the "Company"), a biotech/agtech R&D company engaged in the development of therapeutic, medicinal and nutritional product candidates derived from proprietary algal cultures, announces it has uplisted the trading of shares of its common stock from the OTC Pink Market to the OTCQB Venture Market (OTCQB), effective as of the opening of trading on Friday, January 26, 2024
BusinesswireJan 29 08:00 ET
Analysts Are Bullish on Top Healthcare Stocks: Agenus (AGEN), Zivo Bioscience (ZIVO)
TipRanksJan 25 08:00 ET
ZIVO Bioscience Reports Positive Efficacy Results From 42-Day Validation Study With Non-Antibiotic Immune-Modulating Product for the Prevention and Treatment of Coccidiosis in Broiler Chickens
BLOOMFIELD HILLS, Mich.--(BUSINESS WIRE)--Zivo Bioscience, Inc. (OTC PINK: ZIVO) (the "Company"), a biotech/agtech R&D company engaged in the development of therapeutic, medicinal and nutritional prod
BusinesswireJan 23 08:00 ET
11 Consumer Staples Stocks Moving In Thursday's Intraday Session
GainersSafety Shot (NASDAQ:SHOT) stock increased by 21.5% to $2.77 during Thursday's regular session. Trading volume for Safety Shot's stock is 3.0 million as of 12:30 EST. This is 351.7% of its avera
BenzingaNov 16, 2023 12:31 ET
$2.8M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying
Although U.S. stocks closed higher on Monday, there were a few notable insider trades. When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the sto
BenzingaOct 31, 2023 06:34 ET
Zivo Bioscience Insider Bought Shares Worth $199,600, According to a Recent SEC Filing
Mark E Strome, 10% Owner, on June 02, 2021, executed a purchase for 40,000 shares in Zivo Bioscience (ZIVO) for $199,600. Following the Form 4 filing with the SEC, Strome has control over a total of 2
MT NewswiresOct 30, 2023 17:06 ET
ZIVO Bioscience Initiates 42-Day Validation Study With Immune-Modulating Product for the Prevention and Treatment of Coccidiosis in Broiler Chickens
Zivo Bioscience, Inc. (NASDAQ:ZIVO) (the "Company"), a biotech/agtech R&D company engaged in the development of therapeutic, medicinal and nutritional product candidates derived from proprietary algal cultures,
BusinesswireOct 30, 2023 08:30 ET
Zivo Bioscience to Effect Reverse Stock Split to Regain Compliance With Nasdaq Rules
Seeking AlphaOct 26, 2023 09:10 ET
ZIVO Bioscience Announces Reverse Stock Split >ZIVO
ZIVO Bioscience Announces Reverse Stock Split >ZIVO
Dow JonesOct 26, 2023 08:30 ET
Stocks That Hit 52-Week Lows On Thursday
On Thursday, 369 companies hit new 52-week lows. Noteworthy Points From Today's 52-Week Lows: The largest company in terms of market cap to set a new 52-week low was Coca-Cola (NYSE:KO).The smallest
BenzingaOct 5, 2023 13:22 ET
Orchard Therapeutics, Longeveron Among Healthcare Movers
Seeking AlphaOct 5, 2023 10:00 ET
Zivo Bioscience to Offer Stock, Together With Warrants
Zivo Bioscience to Offer Stock, Together With Warrants
Dow JonesOct 4, 2023 17:18 ET
ZIVO Bioscience to Present at the Dawson James Small Cap Growth Conference
BLOOMFIELD HILLS, Mich, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Zivo Bioscience, Inc. (NASDAQ:ZIVO) (the "Company"), a biotech/agtech R&D company engaged in the development of therapeutic, medicinal and nutritional
GlobeNewswireOct 3, 2023 08:30 ET
Trial Results Confirm Efficacy of ZIVO Bioscience's Non-Antibiotic Product Candidate for the Prevention and Treatment of Coccidiosis in Broiler Chickens
All test groups demonstrated statistically significant benefit in broiler health under simulated commercial conditions Zivo Bioscience, Inc. (NASDAQ:ZIVO) (the "Company"), a biotech/agtech R&D company engaged in
BusinesswireSep 19, 2023 16:15 ET
Zivo Bioscience: ZWorldwide to Buy All Zivolife Supply for First 18 Months of Agreement
By Denny Jacob Zivo Bioscience said distributor ZWorldwide would purchase all supply of Zivolife for the first 18 months as part of a commercial agreement. The biotech/agtech research & development
Dow JonesAug 16, 2023 15:28 ET
ZIVO Announces Commitment by ZWorldwide to Purchase All Zivolife Algal Biomass Product Produced Over the Next 18 Months
ZWorldwide Commits to Minimum Annual Volume Purchases for Five Years ZIVO's Partner Alimenta Expects to Have Significantly Expanded Production Capacity Fully Operational in 2025 to Meet Projected Demand Zivo
BusinesswireAug 16, 2023 08:30 ET
Zivo Filed Prospectus For 2,996,260 Shares Of Common Stock Underlying Series A Common Warrants And Series B Common Warrants By Selling Stockholder
https://www.sec.gov/Archives/edgar/data/1101026/000165495423009761/zivo_s3.htm
BenzingaJul 28, 2023 06:08 ET
No Data
No Data